5 Stocks to Watch: Week of 11/17/2025
Here you go: A fresh batch of stocks to watch for the coming week. All of today’s picks have either A or B (Strong Buy or Buy) ratings from our Zen Ratings system, including:
- Why analysts believe Five9 (FIVN) could double in the coming year
- MKS (MKSI) just crushed earnings — again
- Tapestry (TPR) could be an amazing buy the dip opportunity
- Analysts project “line go up” action for Nerdwallet Inc (NRDS)
- The real reason why Insulet (PODD) has a competitive advantage
- Infusystem Holdings (INFU) just got an upgrade following strong earnings
Let's get to it. (Missed last week's picks? Get them here.)
A note from our sponsors...
How to Become Your Own Bank (And Earn 30-400% Annually) A former Wall Street insider with a CFA Charter is showing crypto investors how to "become their own bank". This select group is using the same liquidity strategy BlackRock uses to dominate traditional markets... except in crypto where returns are exponentially higher. This allows them to generate income regardless of market direction. Regular investors are already earning up to triple-digit annual returns. Click here for the free training to learn how you can earn an extra 30-400% on your digital assets.1- Nerdwallet Inc (NASDAQ: NRDS)
NerdWallet operates a personal finance platform providing educational content, comparison tools, and product marketplaces to help consumers make informed financial decisions. The company's Q3 2025 results surpassed estimates, and with shares up 53% over three months, momentum is building as the company benefits from strong execution and improving market conditions.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $13.85 — get current quote
Max 1-year forecast: $19.00
Why we're watching:
- Analyst support: NRDS commands a Strong Buy consensus among the analysts we track, indicating Smart Money’s seal of approval. See the ratings
- For example, Truist Securities' Youssef Squali (a top 2% rated analyst) maintains a Strong Buy rating with a $19 price target, representing 31.03% upside potential and the highest target among covering analysts.
- Barclays researcher Ross Sandler (a top 9% rated analyst) and KeyBanc's Justin Patterson (a top 8% rated analyst) both maintain Strong Buy ratings with targets of $17 and $16 respectively, citing the company's margin expansion opportunities and strategic positioning.
- Industry ranking context: NRDS is currently the 4th highest-rated stock in the Internet Content & Information industry, which has an Industry Rating of B out of 54 companies tracked.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — NRDS ranks in the top 5% of all stocks tracked with particularly impressive Financials (A grade).
- The company also demonstrates balanced strength with Momentum (B grade) and Value (B grade) complementing its excellent financial health metrics. See all 7 Zen Component Grades here
2- MKS (NASDAQ: MKSI)
MKS provides instruments, systems, and process control solutions for semiconductor manufacturing and other advanced industries worldwide. After delivering Q3 results that beat earnings expectations and raising guidance, the stock has surged to fresh highs, demonstrating strong momentum as the semiconductor equipment cycle recovers.
Zen Rating: B (Buy) — see full analysis
Recent Price: $139.28 — get current quote
Max 1-year forecast: $185.00
Why we're watching:
- Analyst support: MKSI receives solid overall backing from the analysts we track with 4 Strong Buy ratings, 2 Buy ratings, 1 Hold rating, and 1 Strong Sell rating. See the ratings
- Looking at the more bullish takes, Benchmark's Mark Miller (a top 2% rated analyst) and KeyBanc's Steve Barger (a top 5% rated analyst) both maintain Strong Buy ratings with $180 price targets, representing 17.93% upside potential from current levels.
- Industry ranking context: MKSI is currently the #1 highest-rated stock in the Scientific & Technical Instrument industry, which has an Industry Rating of B out of 24 companies tracked.
- Zen Rating highlights: Buy (B) stocks average +19.88% per year — MKSI has market-beating potential.
- Component Grades: The company demonstrates outstanding performance across Value, Safety, Sentiment, and AI (B grades), positioning it as a rare combination of value and growth. (See all 7 Zen Component Grades here)
A note from our sponsors...
Here's the Best Day to Buy Stocks Did you know the S&P 500 has a 100% history of soaring, beginning on one particular day every fall? We call this the "Green Day phenomenon." It works on 5,000 stocks. For example, Nvidia has a 100% history of soaring beginning on one particular day every single year. Click here to see the green days for 7 major stocks today.3- Five9 (NASDAQ: FIVN)
Five9 provides cloud-based contact center software solutions, delivering virtual contact center platforms that enable companies to manage customer service operations efficiently. Despite recent stock pressure, the company posted strong Q3 results and maintains robust analyst support.
Zen Rating: B (Buy) — see full analysis
Recent Price: $19.97 — get current quote
Max 1-year forecast: $40.00
Why we're watching:
- Analyst support: FIVN has a Strong Buy consensus among the analysts we track, with 6 Strong Buy ratings and 2 Hold ratings. See the ratings
- For instance, Barclays researcher Raimo Lenschow (a top 2% rated analyst) recently maintained his Strong Buy rating with a $29 price target, implying 42.65% upside potential. This came on the heels of a double earnings beat.
- In addition, the company also just announced a share repurchase program for up to $150M of common stock, inclusive of a $50M accelerated share repurchase. Per the company CEO, this “demonstrates the conviction of our Board and management team in the strength of our business and long-term value creation opportunity.”
- Zen Ratings vets FIVN with an overall B (Buy) rating, putting the stock in a class of winners that have historically delivered 19.88% annual returns.
- The Component Grades show several areas of strength, including above-average B ratings for Value, Growth, and Artificial Intelligence (here’s how that rating works) — despite a D grade for Momentum, FIVN has several ingredients for near-term success. (See all 7 Component Grades here)
_____________________________
⚡ Seeking Alpha's Black Friday Flash Sale: Save Up To 28% through December 9th
✓ Seeking Alpha Premium — $299 $239/year (save $60) + 7-day free trial for new users
✓ Alpha Picks — $499 $399/year (save $100) | Portfolio up +244% since 2022
✓ Bundle — $798 $574/year (save $224) | Best Value
Rare discounts — won’t see pricing this low again until 2026.
_____________________________
4- Tapestry (NYSE: TPR)
Tapestry (TPR), a suite of luxury retail brands, has gained over 30% since we added it to the Zen Investor portfolio — it recently dipped, so now could be a great entry point. It delivered a strong double beat in its last quarterly report; when you factor in a robust direct-to-consumer model, strong growth in online sales, and ambitious forecasts, it’s clear why Tapestry deserves a closer look.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $99.00 — get current quote
Max 1-year forecast: $147.00
Why we're watching:
- Analyst support: 8 Strong Buy, 4 Buy, and 2 Hold ratings set a positive consensus outlook, with several firms reiterating their bullish stance following Tapestry’s Q1 beat and upwardly revised guidance. See the ratings
- Forbes analysts highlight the stock as a rally candidate after Tapestry overcame a 10% post-earnings drop with record results and a growing Gen Z customer base, suggesting the market overreacted.
- Stock of the Week: According to our Zen Investor Editor in Chief, now’s the time to buy the dip on TPR — click here to find out why.
- Industry ranking context: TPR is the #1 highest-rated stock in the Luxury industry (Industry Rating: A).
- Zen Rating highlights: As an A-rated (Strong Buy) stock, TPR is at home with fellow stocks that have averaged +32.52%/yr Component Grades: TPR has stellar fundamentals, with standout scores in Financials (A), Growth (B), and Momentum (B). The bottom line? TPR has whipped industry peers with outstanding total and annualized returns since IPO. (See all 7 Zen Component Grades here)
5- Infusystem Holdings (NYSEMKT: INFU)
InfuSystem provides crucial services for oncology patients and their care providers. The company's Q3 2025 results met revenue expectations while beating on earnings, with management focused on margin expansion through operational efficiency improvements in its core Oncology business — and Smart Money has taken notice. Here’s why…
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $10.24 — get current quote
Max 1-year forecast: $15.00
Why we're watching:
- Analyst support: INFU only has 2 ratings from analysts we cover, but they are both Strong Buys, reflecting confidence in the company's potential heading into 2026. See the ratings
- For a closer look — Roth Capital analyst Kyle Bauser (a top 22% rated analyst) recently reiterated his Strong Buy rating with a $14 price target following Q3 earnings, noting that while revenue estimates were reduced slightly, adjusted EBITDA and EPS estimates increased due to profitability improvements and share buybacks reducing the share count.
- The price action is right — shares have surged 21.51% over the past three months.
- Industry ranking context: INFU is currently the 3rd highest-rated stock in the Medical industry, which has an Industry Rating of B out of 45 companies tracked.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — INFU demonstrates exceptional momentum characteristics with Safety and Financials earning A ratings. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.